Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (<scp>MCL</scp>) ‐ outcomes and mutation profile from venetoclax resistant <scp>MCL</scp> patients

Shuangtao Zhao, Preetesh Jain, Wendy Chen et al.|American Journal of Hematology|2020

Cited by 84